(Q48291460)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Glutamate in the human brain: possible roles in synaptic transmission and ischemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

3

Langmoen IA

1 reference

10 February 2018

J Berg-Johnsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T S Haugstad

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

I A Langmoen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

Progress in Brain Research

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

287-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

Redistribution of glutamate and glutamine in slices of human neocortex exposed to combined hypoxia and glucose deprivation in vitro.

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

An alternative method for the quantitation of neuronal damage after experimental middle cerebral artery occlusion in rats: analysis of behavioral deficit.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Nonvesicular release of neurotransmitter.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Bursting in human epileptogenic neocortex is depressed by an N-methyl-D-aspartate antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Changes in amino acid release and membrane potential during cerebral hypoxia and glucose deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The NMDA receptor antagonist eliprodil (SL 82.0715) blocks voltage-operated Ca2+ channels in rat cultured cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Immunohistochemical distribution of metabotropic glutamate receptor subtypes mGluR1b, mGluR2/3, mGluR4a and mGluR5 in human hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Glutamate receptor subtype expression in human postmortem brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Massive persistent release of excitatory amino acids following human occlusive stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Progression of ischaemic stroke and excitotoxic aminoacids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Ionic dependence of glutamate neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Effects of a novel NMDA receptor antagonist on experimental stroke quantitatively assessed by spectral EEG and infarct volume

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Duration of glutamate release after acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Uptake of gamma-aminobutyric acid and L-glutamic acid by synaptosomes from postmortem human cerebral cortex: multiple sites, sodium dependence and effect of tissue preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Glutamate: A Neurotransmitter in Mammalian Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Reassessment of [3H]glutamate binding to human brain membrane preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Excitatory amino acid AMPA receptor mRNA localization in several regions of normal and neurological disease affected human brain. An in situ hybridization histochemistry study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Amino acid neurotoxicity: intracellular sites of calcium accumulation associated with the onset of irreversible damage to rat cerebellar neurones in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Neurotoxicity of excitatory amino acid receptor agonists in young rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The free amino acids in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Systemic and cerebral hemodynamic responses to the noncompetitive N-methyl-D-aspartate (NMDA) antagonist CNS 1102

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Cytotoxic effect of Ca++ released from intracellular stores during cerebral energy deprivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Confocal laser scanning microscopy used to monitor intracellular Ca2+ changes in hippocampal CA 1 neurons during energy deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Depletion of intracellular Ca2+ stores or lowering extracellular calcium alters intracellular Ca2+ changes during cerebral energy deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The neuronal environment after subarachnoid haemorrhage--correlation of amino acid and nucleoside levels with post-operative recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Calcium dependent release of gamma-aminobutyric acid (GABA) from human cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Changes in brain amino acid content induced by hyposmolar stress and energy deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Calcium-dependent release of glutamate from human cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Amino-acid release from human cerebral cortex during simulated ischaemia in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Neurometabolic monitoring of the ischaemic human brain using microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Excitatory synaptic transmission mediated by NMDA and non-NMDA receptors in the superficial/middle layers of the epileptogenic human neocortex maintained in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Extracellular accumulation of glutamate in the hippocampus induced by ischemia is not calcium dependent--in vitro and in vivo evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The novel N-methyl-D-aspartate (NMDA) antagonist CGS 19755 prevents ischemia-induced reductions of adenosine A1, NMDA, and PCP receptors in gerbil brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The excitant amino acids glutamic and aspartic acid as transmitter candidates in the vertebrate central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Glucose-induced decrease in glutamate levels in ischemic human brain by in-vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Calcium-dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Ca2+-dependent and Ca2+-independent glutamate release, energy status and cytosolic free Ca2+ concentration in isolated nerve terminals following metabolic inhibition: possible relevance to hypoglycaemia and anoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The toxic effect of sodium L-glutamate on the inner layers of the retina.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The toxic effect of sodium glutamate and DL-alpha-aminoadipic acid on rat retina: changes in high affinity uptake of putative transmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Effects of glycine receptor antagonism on spreading depression in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Excitatory amino acid neurotoxicity and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

EC-IC bypass improves chronic ischemia in a patient with moyamoya disease secondary to sickle cell disease: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

An investigation into the effects of glutamic acid on human intelligence

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-D-aspartate antagonist and reperfusion in experimental stroke in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Clinical experience with excitatory amino acid antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Clinical pharmacology of CNS 1102 in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

45Ca accumulation in rat brain after closed head injury; attenuation by the novel neuroprotective agent HU-211

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Lesions to Schaffer collaterals prevent ischemic death of CA1 pyramidal cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

First SPET images of glutamate (NMDA) receptor activation in vivo in cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Amino acid abnormalities in epileptogenic foci

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Lack of neuroprotective effect of some sigma ligands in a model of focal cerebral ischemia in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

(+)-[3H]MK-801 binding sites in postmortem human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The neurotoxicity of excitatory amino acids is produced by passive chloride influx.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Extracellular glial fibrillary acidic protein and amino acids in brain regions of patients with subarachnoid hemorrhage--correlation with level of consciousness and site of bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Intracerebral microdialysis of glutamate and aspartate in two vascular territories after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Ischemic flow threshold for extracellular glutamate increase in cat cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Spermidine enhancement of [3H]MK-801 binding to the NMDA receptor complex in human cortical membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

A comparison of [3H]MK-801 and N-[1-(2-thienyl)cyclohexyl]-3,4-[3H]piperidine binding to the N-methyl-D-aspartate receptor complex in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Localization of transmitter candidates in the brain: the hippocampal formation as a model

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

First visualization of glutamate and GABA in neurones by immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Ultrastructural immunocytochemical observations on the localization, metabolism and transport of glutamate in normal and ischemic brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Primary structure and functional expression of the AMPA/kainate receptor subunit 2 from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Protection by NMDA antagonists against selective cell loss following transient ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Nature and extent of the biochemical lesion in human epileptogenic cerebral cortex; an approach to its control in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Amino acid content of epileptogenic human brain: Focal versus surrounding regions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Evidence for amelioration of ischaemic neuronal damage in the hippocampal formation by lesions of the perforant path.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Effect of glutamic acid on the intelligence of patients with mongolism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

Development of HU-211 as a neuroprotectant for ischemic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960444-6

7 January 2021

10.1016/S0079-6123(08)60444-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9932384%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference